PDCD1 and glioblastoma: For example, C-X-C motif chemokine receptor 4 (CXCR4) is commonly overexpressed in tumor-associated MDSCs, and anti-CXCR4 therapy can synergize with anti-PD-1 therapy to increase the survival of GBM tumor-bearing mice [252].